Stifel Nicolaus Maintains Buy on Macrogenics, Lowers Price Target to $21

Stifel Nicolaus maintains Macrogenics (NASDAQ:MGNX) with a Buy and lowers the price target from $25 to $21.

Benzinga · 11/07/2019 17:06

Stifel Nicolaus maintains Macrogenics (NASDAQ:MGNX) with a Buy and lowers the price target from $25 to $21.